DrugPatentWatch Database Preview
Ampicillin/ampicillin trihydrate - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for ampicillin/ampicillin trihydrate and what is the scope of patent protection?
Ampicillin/ampicillin trihydrate
is the generic ingredient in fourteen branded drugs marketed by Parke Davis, Am Antibiotics, Dava Pharms Inc, Heritage Pharma, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Sandoz, Vitarine, Wyeth Ayerst, Pfizer, Bristol, Apothecon, Bristol Myers Squibb, Glaxosmithkline, Teva, and Acp Nimble, and is included in forty-three NDAs. Additional information is available in the individual branded drug profile pages.Six suppliers are listed for this compound.
Summary for ampicillin/ampicillin trihydrate
| US Patents: | 0 |
| Tradenames: | 14 |
| Applicants: | 18 |
| NDAs: | 43 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 98 |
| Clinical Trials: | 1 |
| Patent Applications: | 6,825 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ampicillin/ampicillin trihydrate at DailyMed |
Recent Clinical Trials for ampicillin/ampicillin trihydrate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for ampicillin/ampicillin trihydrate
| Drug Class | Penicillin-class Antibacterial |
Synonyms for ampicillin/ampicillin trihydrate
| (2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
| (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| (2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate |
| (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| (2S,5R,6R)-6-[(R)-2-Amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate |
| (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate |
| (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate |
| (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID |
| (6R)-6-(alpha-D-phenylglycylamino)penicillanic acid trihydrate |
| (D-(-)-alpha-Aminobenzyl)penicillin trihydrate |
| 005A175 |
| 1h8s |
| 2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
| 33604-21-6 |
| 37234-64-3 |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2R)-aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S,5R,6R)- |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2R)-aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, trihydrate, (2S,5R,6R)- |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))- |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, trihydrate, (2S-(2alpha,5alpha,6beta(S*)))- |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, D-(-)- |
| 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, trihydrate, D- (-)- |
| 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)- |
| 47355-94-2 |
| 50584-05-9 |
| 6-((2R)-2-amino-2-phenylacetylamino)(2S,5R,6R)-3,3-dimethyl-7-oxo-4-thia-1-aza bicyclo[3.2.0]heptane-2-carboxylic acid |
| 6-((2R)-2-amino-2-phenylacetylamino)(2S,5R,6R)-3,3-dimethyl-7-oxo-4-thia-1-aza bicyclo[3.2.0]heptane-2-carboxylic acid, oxamethane, oxamethane, oxamethane |
| 6-(a-Aminophenylacetamido)penicillanic acid |
| 6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
| 6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid |
| 6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI |
| 6-D(-)-alpha-Aminophenylacetamido-penicillanic acid |
| 69-52-3 |
| 69-52-3 (mono-hydrochloride salt) |
| 69-53-4 |
| 69-53-4 (Parent) |
| 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid |
| 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid trihydrate |
| 7177-48-2 |
| 7177-48-2 (TRIHYDRATE) |
| 7C782967RD |
| 800-79-3 |
| 8056-87-9 |
| 96707-69-6 |
| 98520-55-9 |
| A-8689 |
| AB-PC |
| AB-PC Sol |
| AB1009248 |
| ABPC |
| AC-8805 |
| AC1L1M46 |
| AC1L2MMH |
| Acillin |
| Adobacillin |
| AK322011 |
| AKOS015888156 |
| AKOS015915153 |
| Alpen |
| Alpha-Aminobenzylpenicillin |
| alpha-Aminobenzylpenicillin trihydrate |
| Amblosin |
| Amcap |
| Amcill |
| Amcill (TN) |
| Amfipen |
| Amfipen V |
| Aminobenzylpenicillin |
| Aminobenzylpenicillin trihydrate |
| Amipenix S |
| Ampen |
| Amperil |
| AMPI |
| Ampi-bol |
| Ampi-Co |
| Ampi-Tab |
| Ampichel |
| Ampicil |
| Ampicilina |
| Ampicilina [INN-Spanish] |
| ampicillanyl |
| ampicillin |
| Ampicillin (anhydrous) |
| AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2) |
| Ampicillin (trihydrate) |
| Ampicillin (USP/INN) |
| Ampicillin [USAN:BAN:INN:JAN] |
| Ampicillin [USAN:INN:BAN:JAN] |
| Ampicillin [USAN:USP:INN:BAN:JAN] |
| Ampicillin 3-wasser |
| Ampicillin A |
| Ampicillin acid |
| Ampicillin anhydrate |
| Ampicillin Anhydrous |
| AMPICILLIN ANHYDROUS, PHARMACEUTICAL GRADE |
| Ampicillin Base |
| Ampicillin hydrate (JP17) |
| AMPICILLIN SODIUM |
| AMPICILLIN TRIHYDRA TE, NON-STERILE USP |
| AMPICILLIN TRIHYDRATE |
| AMPICILLIN TRIHYDRATE (SEE ALSO AMPICILLIN 69-53-4) |
| Ampicillin trihydrate, 96.0-100.5% anhydrous basis (HPLC) |
| Ampicillin trihydrate, British Pharmacopoeia (BP) Reference Standard |
| Ampicillin trihydrate, European Pharmacopoeia (EP) Reference Standard |
| AMPICILLIN TRIHYDRATE, NON-STERILE USP |
| Ampicillin Trihydrate, Pharmaceutical Secondary Standard; Certified Reference Material |
| Ampicillin Trihydrate, Sodium |
| Ampicillin trihydrate, United States Pharmacopeia (USP) Reference Standard |
| Ampicillin trihydrate, VETRANAL(TM), analytical standard |
| Ampicillin, analytical standard |
| Ampicillin, anhydrous |
| Ampicillin, anhydrous, 96.0-100.5% (anhydrous basis) |
| Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard |
| Ampicillin, meets USP testing specifications |
| Ampicillin, United States Pharmacopeia (USP) Reference Standard |
| Ampicillin,(S) |
| AMPICILLIN; D(-)-ALPHA-AMINOBENZYLPENICILLIN; 6-[D(-)-ALPHA-AMINOPHENYLLACETAMIDO]PENICILLANIC ACID |
| Ampicillin/ampicillin monohydrate |
| Ampicillina |
| Ampicillina [DCIT] |
| Ampicilline |
| Ampicilline [INN-French] |
| ampicilline trihydrate |
| Ampicillinum |
| Ampicillinum [INN-Latin] |
| Ampicin |
| Ampifarm |
| Ampikel |
| Ampimed |
| Ampinova |
| Ampipenin |
| Ampipenin, nt3 |
| Ampiscel |
| Ampisyn |
| Ampivax |
| Ampivet |
| Amplacilina |
| Amplin |
| Amplipenyl |
| Amplisom |
| Amplital |
| Ampy-Penyl |
| anhydrous ampicillin |
| Anhydrous ampicillin (JP17) |
| Anhydrous ampicillin, British Pharmacopoeia (BP) Reference Standard |
| API0001474 |
| API0006559 |
| Austrapen |
| AVKUERGKIZMTKX-NJBDSQKTSA-N |
| AY 6108 |
| AY 6108 |
| AY-6108 |
| BA 7305 |
| Bayer 5427 |
| BDBM50350465 |
| BIDD:GT0184 |
| Binotal |
| Bonapicillin |
| BPBio1_000142 |
| BRD-K68432770-001-08-0 |
| Britacil |
| BRL 1341 |
| BRL-1341 |
| BSPBio_000128 |
| BSPBio_001862 |
| C-20591 |
| C06574 |
| C16H19N3O4S.3H2O |
| C16H25N3O7S |
| Campicillin |
| CAS-69-53-4 |
| CAS-7177-48-2 |
| CC-24106 |
| CCG-220114 |
| CCRIS 267 |
| CHEBI:28971 |
| CHEBI:31209 |
| CHEBI:53713 |
| CHEMBL174 |
| CHEMBL453388 |
| Cimex |
| Copharcilin |
| CPD000058352 |
| CS-2741 |
| CTK2F3032 |
| Cymbi |
| D-(-)-.alpha.-Aminobenzylpenicillin |
| D-(-)-|A-Aminobenzylpenicillin; Ampicillin trihydrate |
| D-(-)-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate |
| D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid |
| D-(-)-alpha-Aminobenzylpenicillin |
| D-(-)-alpha-Aminopenicillin |
| D-(-)-Ampicillin |
| D-a-Aminobenzylpenicillin |
| D-Ampicillin |
| D-Cillin |
| D00204 |
| D01251 |
| DB00415 |
| degrees +/-UEthCaA(1)EO |
| degrees +/-UEthI/AO EyE(R) masculineIIi |
| Delcillin |
| Deripen |
| Divercillin |
| DivK1c_000466 |
| Doktacillin |
| DSSTox_CID_2602 |
| DSSTox_CID_83 |
| DSSTox_GSID_20083 |
| DSSTox_GSID_22602 |
| DSSTox_RID_75354 |
| DSSTox_RID_76654 |
| DTXSID4022602 |
| DTXSID9020083 |
| Duphacillin |
| EC 200-709-7 |
| EINECS 200-709-7 |
| Epitope ID:115008 |
| Epitope ID:116057 |
| FT-0602848 |
| FT-0622360 |
| Grampenil |
| Guicitrina |
| Guicitrine |
| HI 63 |
| HMS1568G10 |
| HMS2090I11 |
| HMS2095G10 |
| HMS2233H23 |
| HMS3712G10 |
| HSDB 3009 |
| HXQ6A1N7R6 |
| HY-B0522 |
| I14-6965 |
| IDI1_000466 |
| J10197 |
| KBio1_000466 |
| KBio2_000430 |
| KBio2_002998 |
| KBio2_005566 |
| KBio3_001362 |
| KBioGR_000598 |
| KBioSS_000430 |
| KS-00000FNB |
| KS-5251 |
| KS-R1 |
| Lifeampil |
| LS-1586 |
| LS-1610 |
| LS-169948 |
| Marcillin |
| MFCD00005175 |
| MLS000028405 |
| MLS001074168 |
| mo repen |
| MolPort-001-794-635 |
| MolPort-009-653-442 |
| Morepen |
| NCGC00018160-02 |
| NCGC00023282-03 |
| NCGC00023282-05 |
| NCGC00023282-06 |
| NCGC00178944-03 |
| NCGC00248937-01 |
| NCGC00255127-01 |
| NCGC00258700-01 |
| NCI-C56086 |
| NINDS_000466 |
| Norobrittin |
| Novo-ampicillin |
| NSC 528986 |
| NSC-528986 |
| NSC528986 |
| Nuvapen |
| Olin Kid |
| Omnipen |
| OMNIPEN (AMPICILLIN) |
| Omnipen (TN) |
| Omnipen-N |
| Opera_ID_1630 |
| Orbicilina |
| P 50 |
| P-50 |
| Pen A |
| Pen A Oral |
| Pen Ampil |
| Penbristol |
| Penbritin |
| Penbritin paediatric |
| Penbritin syrup |
| Penbritin-S |
| Penbrock |
| Penicillin, (aminophenylmethyl)- |
| Penicillin, Aminobenzyl |
| Penicline |
| Penimic |
| Pensyn |
| Pentrex |
| Pentrexl |
| Pentrexyl |
| Pentritin |
| Pfizerpen A |
| Pfizerpen-A |
| Polycillin |
| Polycillin-N |
| Polyflex (Veterinary) |
| Ponecil |
| Prestwick0_000114 |
| Prestwick1_000114 |
| Prestwick2_000114 |
| Prestwick3_000114 |
| Princillin |
| Principen |
| Principen '125' |
| Principen '250' |
| Principen '500' |
| Q936 |
| QIDamp |
| Racenacillin |
| Ro-Ampen |
| Rosampline |
| Roscillin |
| RXDALBZNGVATNY-CWLIKTDRSA-N |
| s4148 |
| SAM002564243 |
| SBB063111 |
| SBI-0051283.P003 |
| SCHEMBL3526 |
| Semicillin |
| Semicillin R |
| Servicillin |
| SK-Ampicillin |
| SMP1_000211 |
| SMR000058352 |
| SPBio_000818 |
| SPBio_002067 |
| Spectrum_000050 |
| Spectrum2_000769 |
| Spectrum3_000301 |
| Spectrum4_000149 |
| Spectrum5_000814 |
| SQ 17382 |
| SR-01000000061 |
| SR-01000000061-4 |
| ST077148 |
| Sultamicillin EP Impurity C |
| Sumipanto |
| Supen |
| Synpenin |
| Texcillin |
| Tokiocillin |
| Tolomol |
| Totacillin |
| Totacillin (sodium) |
| Totacillin-N |
| Totalciclina |
| Totapen |
| Tox21_113049 |
| Tox21_113049_1 |
| Tox21_201148 |
| Tox21_301416 |
| Trafarbiot |
| Trifacilina |
| Ukapen |
| ukopen |
| Ultrabion |
| Ultrabron |
| UNII-7C782967RD |
| UNII-HXQ6A1N7R6 |
| VA10275 |
| Vampen |
| Viccillin |
| Viccillin S |
| Vidocillin |
| vidopen |
| WY-5103 |
| Wypicil |
| ZINC3830218 |
US Patents and Regulatory Information for ampicillin/ampicillin trihydrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | PENBRITIN | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 050019-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Wyeth Ayerst | OMNIPEN (AMPICILLIN) | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 060625-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apothecon | PRINCIPEN '250' | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 060127-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Mylan | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061829-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Bristol Myers Squibb | PRINCIPEN | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 061392-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apothecon | PRINCIPEN | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061394-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apothecon | PRINCIPEN '500' | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 050056-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.